Skip to main content
FOLD logo
FOLD
(NASDAQ)
Amicus Therapeutics, Inc.
$14.44-- (--)
Loading... - Market loading

Amicus Therapeutics (FOLD) Stock Price & Financial Analysis

Amicus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.43 - $14.44
52-Week High$14.46
52-Week Low$5.51
Open$14.43
Volume2.99M
Average Volume (3M)2.99M
Market Cap4.45B
Shares Outstanding308.36M
Price to Sales (P/S)7.02
Price to Book (P/B)16.24
EV/EBITDA87.75
Revenue (TTM)634.21M
Net Income (TTM)-27.11M
Free Cash Flow (TTM)29.85M
EPS (TTM)$-0.09
Profit Margin-4.27%
Operating Margin5.44%
Return on Equity (ROE)-9.89%
Debt to Equity1.76
50-Day MA$14.35
200-Day MA$10.15
52-Week Change81.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Amicus Therapeutics

What is the current stock price for FOLD?

As of the latest trading session, FOLD stock trades at $14.44. The 52-week range is $5.51–$14.46, with a day range of $14.43–$14.44.

What is the P/E ratio for FOLD?

The P/E ratio (Price-to-Earnings) for FOLD is shown in the Key Statistics section. This valuation metric helps compare Amicus Therapeutics, Inc. to industry peers.

Does FOLD pay dividends?

Amicus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FOLD?

Based on 1 analyst, the consensus for FOLD is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FOLD?

Amicus Therapeutics's market capitalization is $4.45B, classifying it as a mid-cap company. Amicus Therapeutics operates in the Healthcare sector within the Biotechnology industry.